Gamma Aminobutyric Acid (GABA) Global Market Insights 2026, Analysis and Forecast to 2031

May 2026 | 89 pages | ID: GD7824F9B75BEN
Prof Research

Abstracts

OVERVIEW

The global landscape for functional ingredients is experiencing a profound paradigm shift, with consumers increasingly prioritizing preventive healthcare, mental wellbeing, and holistic nutrition. At the forefront of this movement is Gamma Aminobutyric Acid (GABA), a naturally occurring non-protein amino acid that serves as a crucial inhibitory neurotransmitter in the central nervous system. Widely distributed in both plants and animals, GABA is found in the seeds, rhizomes, and tissue fluids of various botanical sources such as beans, ginseng, and traditional medicinal herbs. In the animal kingdom, GABA is almost exclusively localized within nerve tissues. Brain tissue concentrations typically range from 0.1 to 0.6 milligrams per gram of tissue, with immunological studies indicating that the highest concentrations are found in the substantia nigra of the brain.

As an extensively researched inhibitory neurotransmitter, GABA participates in numerous metabolic activities and exhibits exceptionally high physiological activity. The industry surrounding this potent molecule is expanding rapidly due to its multifaceted health benefits. Physiologically, GABA is celebrated for its ability to promote brain activation, enhance cognitive function, and exhibit anti-epileptic properties. It has become a cornerstone in the natural sleep aid sector, helping to alleviate insomnia and improve sleep architecture. Beyond neurological health, GABA offers substantial benefits in beauty and skincare by nourishing the skin and delaying cerebral aging mechanisms. It effectively supplements the human body's native inhibitory neurotransmitters, showcasing excellent efficacy in lowering blood pressure. Furthermore, GABA has been shown to improve and protect kidney function, inhibit the development of fatty liver and obesity by activating liver function, and regulate immune responses. Daily supplementation of trace amounts of GABA is highly beneficial for cardiovascular health, blood pressure management, and the maintenance of amino acid metabolic balance within the human body.

Financially, the global Gamma Aminobutyric Acid market is positioned for robust commercial expansion. In 2026, the market size is estimated to be within the range of 64 million USD to 120 million USD. Driven by surging consumer awareness, expanding application sectors, and continuous advancements in biomanufacturing technologies, the market is projected to experience a Compound Annual Growth Rate (CAGR) ranging from 6.5% to 9.5% through the year 2031. This impressive trajectory underscores the transition of GABA from a niche nutritional supplement to a mainstream functional ingredient embraced by multinational food, beverage, and pharmaceutical conglomerates.

REGIONAL MARKET ANALYSIS

The global GABA market exhibits distinct regional dynamics, influenced by varying regulatory frameworks, consumer health trends, and local manufacturing capabilities.

• Asia-Pacific (APAC)

The Asia-Pacific region represents the most dynamic and rapidly expanding market for GABA, with an estimated regional growth rate interval of 7.5% to 9.5% over the forecast period. Japan has historically been the pioneer in the commercialization of GABA, integrating it deeply into its Foods for Specified Health Uses (FOSHU) and Foods with Function Claims (FFC) systems. Japanese consumers routinely purchase GABA-fortified chocolates, teas, and relaxation beverages. Meanwhile, mainland China has emerged as a powerhouse in both the consumption and mass production of GABA, leveraging advanced bio-fermentation scale-up capabilities to supply global markets. The rising domestic middle class in China is driving unprecedented demand for sleep aids and stress-relief products. Additionally, Taiwan, China plays a highly strategic role in the APAC market. Enterprises and research institutions in Taiwan, China are heavily involved in the development of sophisticated nutraceutical formulations and the advancement of biotechnological processes, facilitating vital technological exchanges and supplying premium functional ingredients to both domestic and international brands.

• North America

North America is a highly mature yet consistently growing market, with an estimated growth rate interval of 6.5% to 8.5%. The region is largely driven by the United States, where high-stress lifestyles and a widespread focus on mental health have catapulted demand for non-habit-forming sleep aids and cognitive enhancers. The regulatory environment, primarily governed by the FDA's Generally Recognized as Safe (GRAS) status for specific GABA derivatives, has encouraged widespread innovation in the dietary supplement space. North American consumers are increasingly seeking out synergistic blends combining GABA with L-theanine, magnesium, and botanical adaptogens.

• Europe

The European market is characterized by a strong emphasis on clean labels, scientific validation, and natural ingredients, projecting an estimated growth rate interval of 6.0% to 8.0%. Growth in this region is navigated through the stringent regulatory parameters set by the European Food Safety Authority (EFSA), particularly concerning Novel Food regulations. Despite regulatory hurdles, countries such as Germany, the United Kingdom, and France are witnessing a steady increase in demand for functional foods aimed at stress reduction. European consumers show a marked preference for naturally derived, fermentation-based GABA over synthetic alternatives, compelling manufacturers to ensure transparent and sustainable supply chains.

• South America

South America is recognized as an emerging market for functional ingredients, with an estimated growth rate interval of 5.5% to 7.5%. Urbanization, changing dietary habits, and a gradual increase in disposable income in countries like Brazil and Argentina are fostering a new market for health-enhancing supplements. While the market is currently in its nascent stages compared to North America and APAC, the growing awareness of mental health and cardiovascular wellness is laying a solid foundation for future GABA product introductions.

• Middle East and Africa (MEA)

The MEA region is expected to witness steady development, with an estimated growth rate interval of 5.0% to 7.0%. The Gulf Cooperation Council (GCC) countries are leading this growth, driven by government-led health initiatives aimed at combating lifestyle diseases such as hypertension and obesity. As GABA demonstrates efficacy in blood pressure management and weight regulation, its integration into the regional health and wellness sector is highly anticipated, albeit starting from a smaller baseline volume.

MARKET SEGMENTATION BY APPLICATION

The versatility of GABA allows it to be integrated into a wide array of consumer and industrial applications, each exhibiting unique growth patterns and formulation trends.

• Food and Beverage

The food and beverage segment represents one of the fastest-growing applications for GABA. As consumers increasingly blur the lines between food and medicine, functional foods have surged in popularity. GABA is being aggressively incorporated into ready-to-drink (RTD) teas, functional waters, dairy products, and confectionery items. The trend is particularly strong in the functional snacking sub-segment, where GABA-infused chocolates and gummies are marketed for evening relaxation and stress mitigation during the workday. Beverage manufacturers are continuously innovating to mask the mild sensory profile of GABA, ensuring that the final products are both efficacious and highly palatable. The trajectory for this segment is characterized by a shift toward mainstream retail channels, moving GABA out of specialized health stores and into everyday grocery aisles.

• Dietary Supplements

Dietary supplements constitute the traditional and most established application for GABA. Available in various formats such as capsules, tablets, softgels, and bulk powders, this segment caters to consumers seeking targeted therapeutic dosages. The primary growth driver in this category is the global sleep crisis. GABA is highly sought after as a natural alternative to pharmacological sleep aids and is frequently formulated alongside melatonin, valerian root, and chamomile. Furthermore, the sports nutrition sector is beginning to adopt GABA due to its potential role in stimulating the release of human growth hormone (HGH), thereby aiding in muscle recovery and fat metabolism. The trend within supplements is moving towards customized, stackable nootropics aimed at comprehensive cognitive health.

• Others (Cosmetics, Pharmaceuticals, and Animal Nutrition)

The “Others” category encompasses several highly lucrative niche applications. In the cosmetics and personal care industry, GABA is celebrated as a 'neurocosmetic' ingredient. Applied topically, it is marketed for its ability to relax facial muscles, thereby reducing the appearance of fine lines and wrinkles, while simultaneously strengthening the skin barrier and promoting cellular renewal. In the pharmaceutical realm, GABA and its structural analogs are utilized in treatments for epilepsy, neuropathic pain, and severe anxiety disorders. Meanwhile, in animal nutrition, GABA is increasingly utilized as a feed additive to mitigate heat stress in livestock, improve meat quality, and enhance overall feed conversion ratios in the poultry and swine industries. Pet care is also a rising sub-segment, with GABA being added to canine and feline treats to reduce separation anxiety and promote calmness.

INDUSTRY CHAIN AND VALUE CHAIN STRUCTURE

Understanding the GABA market requires a comprehensive analysis of its intricate industry and value chain, which stretches from raw agricultural commodities to sophisticated end-user applications.

• Upstream Value Chain: Raw Materials and Feedstocks

The genesis of the GABA value chain relies on the procurement of high-quality raw materials. The predominant method of modern GABA production is microbial fermentation, which utilizes substrates such as glucose, sucrose, corn steep liquor, and primarily L-glutamic acid or monosodium glutamate (MSG). The stability and pricing of the GABA market are therefore inherently linked to the agricultural sector, particularly the global production of corn, sugarcane, and soybeans, which provide the foundational carbon and nitrogen sources for bacterial cultivation.

• Midstream Value Chain: Manufacturing and Bioprocessing

The midstream sector is where the highest technological value is added. It involves the complex process of bio-fermentation, typically utilizing strains of Lactic Acid Bacteria (LAB) such as Lactobacillus brevis or Lactobacillus hilgardii, which possess high glutamate decarboxylase (GAD) activity. This stage includes upstream strain engineering, bioreactor scaling, and critical downstream processing. Downstream processing involves cell separation, ultrafiltration, ion-exchange chromatography, crystallization, and drying to achieve high-purity GABA isolates. Efficiency, yield optimization, and energy consumption at this stage determine the competitive pricing and profit margins of the key market players.

• Downstream Value Chain: Formulation and Brand Integration

Once purified, bulk GABA is distributed to downstream formulators and fast-moving consumer goods (FMCG) companies. Here, value is generated through synergistic formulation, taste masking, and bioavailability enhancements. Nutritional brands, cosmetic houses, and food manufacturers blend GABA with other active ingredients to create targeted consumer products. This stage also involves rigorous quality control, regulatory compliance, and shelf-life stability testing.

• Retail and Consumer End-Point

The final link in the value chain encompasses the distribution networks, including pharmacies, hypermarkets, specialized health food stores, and e-commerce platforms. Marketing strategies, consumer education, and brand positioning play pivotal roles in capturing value at this stage, ultimately delivering the health benefits of GABA to the health-conscious end-user.

KEY ENTERPRISE INFORMATION

The competitive landscape of the GABA market is populated by a mix of specialized biotechnology firms, large-scale fermentation experts, and comprehensive ingredient suppliers. The following enterprises are at the forefront of shaping the industry:

• Shandong Freda

Shandong Freda is a formidable entity in the biotechnology and biochemical sector. Leveraging a profound historical background in the fermentation of hyaluronic acid and other bioactive molecules, the company has successfully translated its biomanufacturing expertise into the production of high-quality GABA. Shandong Freda is known for its rigorous quality control standards and its ability to serve both the cosmetic and dietary supplement industries, integrating deep research and development with large-scale commercialization.

• Pharma Foods International Co. Ltd.

Headquartered in Japan, Pharma Foods International is a true pioneer and a highly recognized name in the global GABA market. The company is famous for its proprietary 'PharmaGABA,' a naturally fermented ingredient derived using Lactobacillus hilgardii, a bacteria traditionally used in the fermentation of Korean kimchi. Pharma Foods International has been instrumental in generating clinical data supporting the efficacy of GABA, thereby driving consumer trust and facilitating the widespread adoption of GABA into mainstream Japanese food and beverage products.

• Zhejiang Yiwan

Zhejiang Yiwan operates as a key player in the biological engineering and food additive sectors. The company has carved out a significant market share by focusing on supply chain reliability, cost-effective manufacturing, and stringent compliance with international food safety standards. Zhejiang Yiwan supplies bulk GABA to numerous international formulators, acting as a critical node in the global nutritional supply chain.

• Shandong Yangcheng Biotechnology Co. Ltd

Specializing in industrial-scale bio-fermentation, Shandong Yangcheng Biotechnology Co. Ltd focuses on maximizing yield and optimizing production costs. Their massive bioreactor capacities allow them to meet the surging global demand for functional amino acids. The company's strategic focus is on operational excellence, ensuring a steady, high-volume supply of GABA to the rapidly expanding food, beverage, and animal feed markets.

• Tai'an Synceres

Tai'an Synceres represents the cutting-edge intersection of synthetic biology and green manufacturing. By employing advanced genetic engineering and directed evolution of microbial strains, Tai'an Synceres aims to push the boundaries of fermentation efficiency. Their innovative approaches not only improve the purity and yield of GABA but also significantly reduce the environmental footprint of the manufacturing process, aligning with the global industry's shift towards sustainable bio-manufacturing.

• Henan Julong Biological Engineering Co. LTD.

Henan Julong Biological Engineering is deeply entrenched in the amino acid and bio-fermentation industry. The company possesses extensive technical know-how in the metabolic pathways of amino acids. Their robust research infrastructure allows them to continuously refine their fermentation substrates and downstream purification techniques, positioning them as a highly reliable supplier of premium-grade GABA for both pharmaceutical and nutraceutical applications.

MARKET OPPORTUNITIES

The Gamma Aminobutyric Acid market is brimming with expansive opportunities, catalyzed by shifting consumer lifestyles and scientific advancements.

• The Mental Wellness Megatrend

The modern era is witnessing an unprecedented global mental health crisis, characterized by chronic stress, anxiety, and widespread sleep deprivation. As consumers actively seek natural, non-addictive alternatives to synthetic pharmaceuticals, GABA stands to benefit immensely. The growing destigmatization of mental health care is encouraging proactive daily supplementation, opening vast opportunities for daily-use GABA products that promote a state of calm and mental clarity without causing drowsiness.

• Expansion into Sports Nutrition and E-Sports

Beyond traditional wellness, the sports nutrition sector offers a lucrative frontier. GABA's potential to support muscle recovery through the stimulation of growth hormones is attracting the attention of athletes and bodybuilders. Concurrently, the booming E-sports and competitive gaming industry requires nutritional interventions that enhance sustained focus while mitigating the physical and mental stress of prolonged screen time. GABA-infused energy and recovery drinks tailored for gamers represent a highly promising, untapped demographic.

• Advancements in Neurocosmetics

The beauty industry's pivot towards neurocosmetics—products that link skin health with the nervous system—provides a unique avenue for GABA. Topical formulations leveraging GABA's muscle-relaxing properties to simulate a 'natural botox' effect, alongside its skin-soothing and barrier-repairing capabilities, are gaining immense traction among aging populations seeking non-invasive anti-aging solutions.

• Green Biomanufacturing and Sustainability

As global supply chains face pressure to decarbonize, the inherent nature of GABA production via microbial fermentation presents an opportunity. Companies that can pioneer zero-waste fermentation processes, utilize upcycled agricultural byproducts as fermentation substrates, and minimize water usage will gain significant competitive advantages and premium pricing power in environmentally conscious markets, particularly in Europe and North America.

MARKET CHALLENGES

Despite a highly optimistic growth forecast, the GABA market must navigate several complex challenges that could impede optimal expansion.

• Blood-Brain Barrier (BBB) Permeability Debates

A persistent scientific and marketing challenge revolves around the debate over GABA's ability to cross the blood-brain barrier when administered orally. While extensive anecdotal evidence and numerous clinical trials demonstrate its efficacy in reducing stress and inducing sleep, the exact pharmacokinetic mechanisms remain a subject of academic debate. The industry faces the continuous challenge of investing in rigorous clinical research to substantiate physiological claims and educate consumers, combating skepticism from the traditional medical community.

• Formulation Stability and Sensory Limitations

Integrating GABA into diverse food and beverage matrices presents significant biochemical challenges. In liquid applications, particularly those subjected to high-temperature processing like ultra-high temperature (UHT) pasteurization, maintaining the stability and bioactivity of GABA can be difficult. Additionally, while generally mild, high concentrations of GABA can impart off-notes or slightly bitter tastes to delicate flavor profiles, necessitating advanced microencapsulation or taste-masking technologies which inevitably increase production costs.

• Regulatory Fragmentation

The global regulatory landscape for functional ingredients is highly fragmented. While GABA enjoys GRAS status in the United States and is widely approved in Japan and South Korea, it faces strict scrutiny under the European Union's Novel Food regulations, limiting its rapid deployment in certain European jurisdictions. Multinational brands must navigate a complex, costly, and time-consuming patchwork of local legislations to launch standardized global products.

• Price Volatility of Raw Substrates

Because the primary substrates for GABA fermentation (such as glutamic acid) are derived from agricultural commodities like corn and soy, the midstream manufacturers are highly exposed to agricultural price volatility. Fluctuations caused by climate change, geopolitical tensions, and supply chain disruptions can compress profit margins, challenging manufacturers to maintain stable pricing for downstream clients.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Sources
  3.2.1 Data Sources
  3.2.2 Assumptions
3.3 Research Method

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Gamma Aminobutyric Acid (GABA) Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Gamma Aminobutyric Acid (GABA) by Region
8.2 Import of Gamma Aminobutyric Acid (GABA) by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND FORECAST GAMMA AMINOBUTYRIC ACID (GABA) MARKET IN NORTH AMERICA (2021-2031)

9.1 Gamma Aminobutyric Acid (GABA) Market Size
9.2 Gamma Aminobutyric Acid (GABA) Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis
  9.5.1 United States
  9.5.2 Canada
  9.5.3 Mexico

CHAPTER 10 HISTORICAL AND FORECAST GAMMA AMINOBUTYRIC ACID (GABA) MARKET IN SOUTH AMERICA (2021-2031)

10.1 Gamma Aminobutyric Acid (GABA) Market Size
10.2 Gamma Aminobutyric Acid (GABA) Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis
  10.5.1 Brazil
  10.5.2 Argentina
  10.5.3 Chile
  10.5.4 Peru

CHAPTER 11 HISTORICAL AND FORECAST GAMMA AMINOBUTYRIC ACID (GABA) MARKET IN ASIA & PACIFIC (2021-2031)

11.1 Gamma Aminobutyric Acid (GABA) Market Size
11.2 Gamma Aminobutyric Acid (GABA) Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis
  11.5.1 China
  11.5.2 India
  11.5.3 Japan
  11.5.4 South Korea
  11.5.5 Southest Asia
  11.5.6 Australia & New Zealand

CHAPTER 12 HISTORICAL AND FORECAST GAMMA AMINOBUTYRIC ACID (GABA) MARKET IN EUROPE (2021-2031)

12.1 Gamma Aminobutyric Acid (GABA) Market Size
12.2 Gamma Aminobutyric Acid (GABA) Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis
  12.5.1 Germany
  12.5.2 France
  12.5.3 United Kingdom
  12.5.4 Italy
  12.5.5 Spain
  12.5.6 Belgium
  12.5.7 Netherlands
  12.5.8 Austria
  12.5.9 Poland
  12.5.10 North Europe

CHAPTER 13 HISTORICAL AND FORECAST GAMMA AMINOBUTYRIC ACID (GABA) MARKET IN MEA (2021-2031)

13.1 Gamma Aminobutyric Acid (GABA) Market Size
13.2 Gamma Aminobutyric Acid (GABA) Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis
  13.5.1 Egypt
  13.5.2 Israel
  13.5.3 South Africa
  13.5.4 Gulf Cooperation Council Countries
  13.5.5 Turkey

CHAPTER 14 SUMMARY FOR GLOBAL GAMMA AMINOBUTYRIC ACID (GABA) MARKET (2021-2026)

14.1 Gamma Aminobutyric Acid (GABA) Market Size
14.2 Gamma Aminobutyric Acid (GABA) Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL GAMMA AMINOBUTYRIC ACID (GABA) MARKET FORECAST (2026-2031)

15.1 Gamma Aminobutyric Acid (GABA) Market Size Forecast
15.2 Gamma Aminobutyric Acid (GABA) Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 ANALYSIS OF GLOBAL KEY VENDORS

16.1 Shandong Freda
  16.1.1 Company Profile
  16.1.2 Main Business and Gamma Aminobutyric Acid (GABA) Information
  16.1.3 SWOT Analysis of Shandong Freda
  16.1.4 Shandong Freda Gamma Aminobutyric Acid (GABA) Sales, Revenue, Price and Gross Margin (2021-2026)
16.2 Pharma Foods International Co. Ltd.
  16.2.1 Company Profile
  16.2.2 Main Business and Gamma Aminobutyric Acid (GABA) Information
  16.2.3 SWOT Analysis of Pharma Foods International Co. Ltd.
  16.2.4 Pharma Foods International Co. Ltd. Gamma Aminobutyric Acid (GABA) Sales, Revenue, Price and Gross Margin (2021-2026)
16.3 Zhejiang Yiwan
  16.3.1 Company Profile
  16.3.2 Main Business and Gamma Aminobutyric Acid (GABA) Information
  16.3.3 SWOT Analysis of Zhejiang Yiwan
  16.3.4 Zhejiang Yiwan Gamma Aminobutyric Acid (GABA) Sales, Revenue, Price and Gross Margin (2021-2026)
16.4 Shandong Yangcheng Biotechnology Co. Ltd
  16.4.1 Company Profile
  16.4.2 Main Business and Gamma Aminobutyric Acid (GABA) Information
  16.4.3 SWOT Analysis of Shandong Yangcheng Biotechnology Co. Ltd
  16.4.4 Shandong Yangcheng Biotechnology Co. Ltd Gamma Aminobutyric Acid (GABA) Sales, Revenue, Price and Gross Margin (2021-2026)
16.5 Tai'an Synceres
  16.5.1 Company Profile
  16.5.2 Main Business and Gamma Aminobutyric Acid (GABA) Information
  16.5.3 SWOT Analysis of Tai'an Synceres
  16.5.4 Tai'an Synceres Gamma Aminobutyric Acid (GABA) Sales, Revenue, Price and Gross Margin (2021-2026)
Please ask for sample pages for full companies list

Tables & Figures

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Gamma Aminobutyric Acid (GABA) Report
Table Data Sources of Gamma Aminobutyric Acid (GABA) Report
Table Major Assumptions of Gamma Aminobutyric Acid (GABA) Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Gamma Aminobutyric Acid (GABA) Picture
Table Gamma Aminobutyric Acid (GABA) Classification
Table Gamma Aminobutyric Acid (GABA) Applications List
Table Drivers of Gamma Aminobutyric Acid (GABA) Market
Table Restraints of Gamma Aminobutyric Acid (GABA) Market
Table Opportunities of Gamma Aminobutyric Acid (GABA) Market
Table Threats of Gamma Aminobutyric Acid (GABA) Market
Table Raw Materials Suppliers List
Table Different Production Methods of Gamma Aminobutyric Acid (GABA)
Table Cost Structure Analysis of Gamma Aminobutyric Acid (GABA)
Table Key End Users List
Table Latest News of Gamma Aminobutyric Acid (GABA) Market
Table Merger and Acquisition List
Table Planned/Future Project of Gamma Aminobutyric Acid (GABA) Market
Table Policy of Gamma Aminobutyric Acid (GABA) Market
Table 2021-2031 Regional Export of Gamma Aminobutyric Acid (GABA)
Table 2021-2031 Regional Import of Gamma Aminobutyric Acid (GABA)
Table 2021-2031 Regional Trade Balance
Figure 2021-2031 Regional Trade Balance
Table 2021-2031 North America Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Figure 2021-2031 North America Gamma Aminobutyric Acid (GABA) Market Size and CAGR
Figure 2021-2031 North America Gamma Aminobutyric Acid (GABA) Market Volume and CAGR
Table 2021-2031 North America Gamma Aminobutyric Acid (GABA) Demand List by Application
Table 2021-2026 North America Gamma Aminobutyric Acid (GABA) Key Players Sales List
Table 2021-2026 North America Gamma Aminobutyric Acid (GABA) Key Players Market Share List
Table 2021-2031 North America Gamma Aminobutyric Acid (GABA) Demand List by Type
Table 2021-2026 North America Gamma Aminobutyric Acid (GABA) Price List by Type
Table 2021-2031 United States Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 United States Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Canada Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Canada Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Mexico Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Mexico Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 South America Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Figure 2021-2031 South America Gamma Aminobutyric Acid (GABA) Market Size and CAGR
Figure 2021-2031 South America Gamma Aminobutyric Acid (GABA) Market Volume and CAGR
Table 2021-2031 South America Gamma Aminobutyric Acid (GABA) Demand List by Application
Table 2021-2026 South America Gamma Aminobutyric Acid (GABA) Key Players Sales List
Table 2021-2026 South America Gamma Aminobutyric Acid (GABA) Key Players Market Share List
Table 2021-2031 South America Gamma Aminobutyric Acid (GABA) Demand List by Type
Table 2021-2026 South America Gamma Aminobutyric Acid (GABA) Price List by Type
Table 2021-2031 Brazil Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Brazil Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Argentina Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Argentina Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Chile Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Chile Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Peru Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Peru Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Asia & Pacific Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Figure 2021-2031 Asia & Pacific Gamma Aminobutyric Acid (GABA) Market Size and CAGR
Figure 2021-2031 Asia & Pacific Gamma Aminobutyric Acid (GABA) Market Volume and CAGR
Table 2021-2031 Asia & Pacific Gamma Aminobutyric Acid (GABA) Demand List by Application
Table 2021-2026 Asia & Pacific Gamma Aminobutyric Acid (GABA) Key Players Sales List
Table 2021-2026 Asia & Pacific Gamma Aminobutyric Acid (GABA) Key Players Market Share List
Table 2021-2031 Asia & Pacific Gamma Aminobutyric Acid (GABA) Demand List by Type
Table 2021-2026 Asia & Pacific Gamma Aminobutyric Acid (GABA) Price List by Type
Table 2021-2031 China Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 China Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 India Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 India Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Japan Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Japan Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 South Korea Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 South Korea Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Southeast Asia Gamma Aminobutyric Acid (GABA) Market Size List
Table 2021-2031 Southeast Asia Gamma Aminobutyric Acid (GABA) Market Volume List
Table 2021-2031 Southeast Asia Gamma Aminobutyric Acid (GABA) Import List
Table 2021-2031 Southeast Asia Gamma Aminobutyric Acid (GABA) Export List
Table 2021-2031 Australia & New Zealand Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Australia & New Zealand Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Europe Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Figure 2021-2031 Europe Gamma Aminobutyric Acid (GABA) Market Size and CAGR
Figure 2021-2031 Europe Gamma Aminobutyric Acid (GABA) Market Volume and CAGR
Table 2021-2031 Europe Gamma Aminobutyric Acid (GABA) Demand List by Application
Table 2021-2026 Europe Gamma Aminobutyric Acid (GABA) Key Players Sales List
Table 2021-2026 Europe Gamma Aminobutyric Acid (GABA) Key Players Market Share List
Table 2021-2031 Europe Gamma Aminobutyric Acid (GABA) Demand List by Type
Table 2021-2026 Europe Gamma Aminobutyric Acid (GABA) Price List by Type
Table 2021-2031 Germany Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Germany Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 France Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 France Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 United Kingdom Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 United Kingdom Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Italy Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Italy Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Spain Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Spain Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Belgium Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Belgium Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Netherlands Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Netherlands Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Austria Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Austria Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Poland Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Poland Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 North Europe Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 North Europe Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 MEA Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Figure 2021-2031 MEA Gamma Aminobutyric Acid (GABA) Market Size and CAGR
Figure 2021-2031 MEA Gamma Aminobutyric Acid (GABA) Market Volume and CAGR
Table 2021-2031 MEA Gamma Aminobutyric Acid (GABA) Demand List by Application
Table 2021-2026 MEA Gamma Aminobutyric Acid (GABA) Key Players Sales List
Table 2021-2026 MEA Gamma Aminobutyric Acid (GABA) Key Players Market Share List
Table 2021-2031 MEA Gamma Aminobutyric Acid (GABA) Demand List by Type
Table 2021-2026 MEA Gamma Aminobutyric Acid (GABA) Price List by Type
Table 2021-2031 Egypt Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Egypt Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Israel Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Israel Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 South Africa Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 South Africa Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Gulf Cooperation Council Countries Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Gulf Cooperation Council Countries Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2031 Turkey Gamma Aminobutyric Acid (GABA) Market Size and Market Volume List
Table 2021-2031 Turkey Gamma Aminobutyric Acid (GABA) Import & Export List
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Market Size List by Region
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Market Size Share List by Region
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Market Volume List by Region
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Market Volume Share List by Region
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Demand List by Application
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Demand Market Share List by Application
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Capacity List
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Key Vendors Capacity Share List
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Key Vendors Production List
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Key Vendors Production Share List
Figure 2021-2026 Global Gamma Aminobutyric Acid (GABA) Capacity Production and Growth Rate
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Key Vendors Production Value List
Figure 2021-2026 Global Gamma Aminobutyric Acid (GABA) Production Value and Growth Rate
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Key Vendors Production Value Share List
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Demand List by Type
Table 2021-2026 Global Gamma Aminobutyric Acid (GABA) Demand Market Share List by Type
Table 2021-2026 Regional Gamma Aminobutyric Acid (GABA) Price List
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Market Size List by Region
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Market Size Share List by Region
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Market Volume List by Region
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Market Volume Share List by Region
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Demand List by Application
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Demand Market Share List by Application
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Capacity List
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Key Vendors Capacity Share List
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Key Vendors Production List
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Key Vendors Production Share List
Figure 2026-2031 Global Gamma Aminobutyric Acid (GABA) Capacity Production and Growth Rate
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Key Vendors Production Value List
Figure 2026-2031 Global Gamma Aminobutyric Acid (GABA) Production Value and Growth Rate
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Key Vendors Production Value Share List
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Demand List by Type
Table 2026-2031 Global Gamma Aminobutyric Acid (GABA) Demand Market Share List by Type
Table 2026-2031 Gamma Aminobutyric Acid (GABA) Regional Price List
Table Shandong Freda Information
Table SWOT Analysis of Shandong Freda
Table 2021-2026 Shandong Freda Gamma Aminobutyric Acid (GABA) Product Capacity Production Price Cost Production Value
Figure 2021-2026 Shandong Freda Gamma Aminobutyric Acid (GABA) Capacity Production and Growth Rate
Figure 2021-2026 Shandong Freda Gamma Aminobutyric Acid (GABA) Market Share
Table Pharma Foods International Co. Ltd. Information
Table SWOT Analysis of Pharma Foods International Co. Ltd.
Table 2021-2026 Pharma Foods International Co. Ltd. Gamma Aminobutyric Acid (GABA) Product Capacity Production Price Cost Production Value
Figure 2021-2026 Pharma Foods International Co. Ltd. Gamma Aminobutyric Acid (GABA) Capacity Production and Growth Rate
Figure 2021-2026 Pharma Foods International Co. Ltd. Gamma Aminobutyric Acid (GABA) Market Share
Table Zhejiang Yiwan Information
Table SWOT Analysis of Zhejiang Yiwan
Table 2021-2026 Zhejiang Yiwan Gamma Aminobutyric Acid (GABA) Product Capacity Production Price Cost Production Value
Figure 2021-2026 Zhejiang Yiwan Gamma Aminobutyric Acid (GABA) Capacity Production and Growth Rate
Figure 2021-2026 Zhejiang Yiwan Gamma Aminobutyric Acid (GABA) Market Share
Table Shandong Yangcheng Biotechnology Co. Ltd Information
Table SWOT Analysis of Shandong Yangcheng Biotechnology Co. Ltd
Table 2021-2026 Shandong Yangcheng Biotechnology Co. Ltd Gamma Aminobutyric Acid (GABA) Product Capacity Production Price Cost Production Value
Figure 2021-2026 Shandong Yangcheng Biotechnology Co. Ltd Gamma Aminobutyric Acid (GABA) Capacity Production and Growth Rate
Figure 2021-2026 Shandong Yangcheng Biotechnology Co. Ltd Gamma Aminobutyric Acid (GABA) Market Share
Table Tai'an Synceres Information
Table SWOT Analysis of Tai'an Synceres
Table 2021-2026 Tai'an Synceres Gamma Aminobutyric Acid (GABA) Product Capacity Production Price Cost Production Value
Figure 2021-2026 Tai'an Synceres Gamma Aminobutyric Acid (GABA) Capacity Production and Growth Rate
Figure 2021-2026 Tai'an Synceres Gamma Aminobutyric Acid (GABA) Market Share
Table Henan Julong Biological Engineering Co. LTD. Information
Table SWOT Analysis of Henan Julong Biological Engineering Co. LTD.
Table 2021-2026 Henan Julong Biological Engineering Co. LTD. Gamma Aminobutyric Acid (GABA) Product Capacity Production Price Cost Production Value
Figure 2021-2026 Henan Julong Biological Engineering Co. LTD. Gamma Aminobutyric Acid (GABA) Capacity Production and Growth Rate
Figure 2021-2026 Henan Julong Biological Engineering Co. LTD. Gamma Aminobutyric Acid (GABA) Market Share
......